Skip to main content

Market Overview

60 Biggest Movers From Yesterday

Share:

Gainers

  • Dare Bioscience Inc (NASDAQ: DARE) shares climbed 131.11 percent to close at $2.10 on Monday after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.
  • Dermira, Inc. (NASDAQ: DERM) shares gained 82.16 percent to close at $12.61 after the company announced that its Phase 2 study of Lebrikizumab met its primary endpoint.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) gained 64.52 percent to close at $6.23 after the New England Journal of Medicine published the positive Phase 1 results for the company's PB2452.
  • Selecta Biosciences, Inc. (NASDAQ: SELB) shares rose 46.54 percent to close at $3.06.
  • Gritstone Oncology, Inc. (NASDAQ: GRTS) shares gained 31.43 percent to close at $13.34.
  • American Midstream Partners, LP (NYSE: AMID) climbed 28.5 percent to close at $5.14 after the company announced that it would be acquired by ArcLight Energy for $5.25 per share.
  • Atossa Genetics Inc. (NASDAQ: ATOS) rose 24.47 percent to close at $4.40 after the company reported the receipt of $10 million from exercises of previously outstanding warrants.
  • Iconix Brand Group, Inc. (NASDAQ: ICON) gained 23.76 percent to close at $2.45.
  • Aclaris Therapeutics, Inc. (NASDAQ: ACRS) gained 19.63 percent to close at $6.78 after the company reported higher-than-expected Q4 sales.
  • Rockwell Medical, Inc. (NASDAQ: RMTI) climbed 19 percent to close at $6.21.
  • Mesoblast Limited (NASDAQ: MESO) rose 18.49 percent to close at $5.17.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) gained 18.03 percent to close at $2.75.
  • Liquid Media Group Ltd. (NASDAQ: YVR) gained 17.35 percent to close at $3.45.
  • Translate Bio, Inc. (NASDAQ: TBIO) climbed 16.63 percent to close at $9.61. Translate Bio highlighted publication of preclinical data demonstrating efficacy of systemic mRNA delivery in Fabry disease model in the Journal Molecular Therapy.
  • Smart Sand, Inc. (NASDAQ: SND) rose 16.42 percent to close at $4.67.
  • DASAN Zhone Solutions, Inc. (NASDAQ: DZSI) rose 15.54 percent to close at $11.81. DASAN Zhone expects Q1 organic revenue of $63 million to $66 million and FY19 organic revenue of $304 million to $310 million.
  • Viomi Technology Co., Ltd (NASDAQ: VIOT) climbed 15.13 percent to close at $12.00 after reporting Q4 results.
  • Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) shares gained 14.94 percent to close at $2.48 after reporting entry into securities purchase agreement to fund initiation of the first Phase 3 celiac disease clinical trial.
  • Village Farms International, Inc. (NASDAQ: VFF) gained 14.01 percent to close at $16.33.
  • Replimune Group, Inc. (NASDAQ: REPL) climbed 13.57 percent to close at $13.13.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) gained 12.95 percent to close at $5.31.
  • Synthorx, Inc. (NASDAQ: THOR) gained 12.23 percent to close at $21.51.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) rose 12.01 percent to close at $4.57 after falling 29.66 percent on Friday.
  • Cellectar Biosciences, Inc. (NASDAQ: CLRB) climbed 11.97 percent to close at $2.74.
  • Overseas Shipholding Group, Inc. (NYSE: OSG) shares rose 11.84 percent to close at $2.55.
  • Digital Turbine, Inc. (NASDAQ: APPS) shares jumped 11.76 percent to close at $3.39 on Monday.
  • AVROBIO, Inc. (NASDAQ: AVRO) gained 11.73 percent to close at $17.63.
  • 360 Finance, Inc. (NASDAQ: QFIN) rose 11.64 percent to close at $16.51.
  • CHF Solutions, Inc. (NASDAQ: CHFS) gained 11 percent to close at $3.92.
  • Triple-S Management Corporation (NYSE: GTS) rose 10.85 percent to close at $27.28.
  • China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) rose 10.82 percent to close at $6.96.
  • Worldpay, Inc. (NYSE: WP) shares gained 9.96 percent to close at $108.51. Fidelity National Information Services Inc (NYSE: FIS) agreed to buy Worldpay for around $35 billion.
  • Oragenics, Inc. (NYSE: OGEN) gained 7.6 percent to close at $0.9576 after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.
  • Cue Biopharma, Inc. (NASDAQ: CUE) rose 7.12 percent to close at $8.56.
  • Avid Technology, Inc. (NASDAQ: AVID) shares rose 5.06 percent to close at $6.53.
  • Deutsche Bank AG (NYSE: DB) rose 4.3 percent to close at $9.26 after confirming it's in merger talks with fellow German-based bank Commerzbank.
  • AzurRx BioPharma, Inc. (NASDAQ: AZRX) shares rose 4.2 percent to close at $2.14 after the company announced it will present Phase II MS1819-SD data at the 2019 Digestive Disease Week Conference.

 

Losers

  • Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) shares tumbled 70.54 percent to close at $1.22 on Monday after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.
  • NII Holdings, Inc. (NASDAQ: NIHD) dropped 27.9 percent to close at $2.27. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.
  • Synaptics Incorporated (NASDAQ: SYNA) shares fell 22.46 percent to close at $33.46 after the company lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman.
  • FutureFuel Corp. (NYSE: FF) shares fell 20.95 percent to close at $14.11 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.
  • Globus Maritime Limited (NASDAQ: GLBS) fell 19.22 percent to close at $4.6100. Globus Maritime reported a Q4 loss of $0.42 per share, on sales of $4.36 million.
  • Sensus Healthcare, Inc. (NASDAQ: SRTS) dropped 16.25 percent to close at $7.90.
  • BioScrip, Inc. (NASDAQ: BIOS) fell 15.47 percent to close at $2.34. Stephens & Co. downgraded BioScrip from Overweight to Equal-Weight.
  • Polarityte Inc (NASDAQ: PTE) fell 15.29 percent to close at $13.05 after the company announced it is the subject of an SEC investigation and used $8M of cash during a 2 month transitional period.
  • Trinity Place Holdings Inc. (NYSE: TPHS) dipped 14.13 percent to close at $4.0100.
  • vTv Therapeutics Inc (NASDAQ: VTVT) fell 13.91 percent to close at $2.0000 after reporting $15 million in Class A common stock financings.
  • PHI, Inc. (NASDAQ: PHII) dipped 12.64 percent to close at $2.49. PHI posted Q4 results on Monday.
  • GP Strategies Corporation (NYSE: GPX) shares dropped 12.63 percent to close at $12.52 after reporting downbeat Q4 results.
  • Qutoutiao Inc. (NASDAQ: QTT) dropped 12.6 percent to close at $13.57.
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) fell 12.1 percent to close at $2.3900 after dropping 3.90 percent on Friday.
  • CohBar, Inc. (NASDAQ: CWBR) dipped 9.74 percent to close at $3.4700.
  • Ra Medical Systems, Inc. (NYSE: RMED) fell 9.71 percent to close at $4.00.
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) dropped 9.67 percent to close at $26.33.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) fell 9.06 percent to close at $3.01.
  • Coda Octopus Group, Inc. (NASDAQ: CODA) dropped 7.69 percent to close at $8.55. Coda Octopus reported Q1 earnings of $0.12 per share on sales of $5.76 million.
  • Huami Corporation (NYSE: HMI) shares fell 6.36 percent to close at $14.44 after gaining 5.91 percent on Friday.
  • Turtle Beach Corporation (NASDAQ: HEAR) dipped 6.31 percent to close at $12.46.
  • Chaparral Energy, Inc. (NYSE: CHAP) shares dropped 6.3 percent to close at $4.4600.
  • Key Energy Services, Inc. (NYSE: KEG) fell 6.02 percent to close at $5.78.
 

Related Articles (ACRS + ADIL)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com